Última Hora: "Pilotos dizem que negociações com a Ryanair ainda estão em curso - Jornal de Negócios - Portugal" Fri, 19 Oct 2018 19:20:24 GMT    "Agência DBRS mantém 'rating' da Madeira no 'lixo' apesar de boas perspetivas futuras - Diário de Notícias - Lisboa" Fri, 19 Oct 2018 23:19:00 GMT    "Estado 'devolve' em deduções 60% do Adicional ao IMI que cobra - Dinheiro Vivo" Sat, 20 Oct 2018 06:14:14 GMT    "'Jackpot' de 58 milhões de euros no próximo sorteio do Euromilhões - Diário de Notícias - Lisboa" Fri, 19 Oct 2018 23:37:52 GMT    "EDP quer exportar tecnologia do maior parque eólico flutuante do mundo - Dinheiro Vivo" Fri, 19 Oct 2018 19:32:00 GMT    "Bruxelas envia carta a Centeno a pedir o triplo do esforço orçamental - Dinheiro Vivo" Fri, 19 Oct 2018 17:30:20 GMT    "Acionistas do Facebook querem derrubar "ditador" Zuckerberg - Diário de Notícias - Lisboa" Fri, 19 Oct 2018 17:16:00 GMT    "Estrangeiros compraram 11,5% do imobiliário em Portugal em 2017 - PÚBLICO" Fri, 19 Oct 2018 13:32:30 GMT    "Há pizas e piratas no novo restaurante de Famalicão - Diário de Notícias - Lisboa" Sat, 20 Oct 2018 05:34:00 GMT   "" Sat, 20 Oct 2018 08:03:28 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Eating Disorders: October 2018
Healio
Sponsorship Statement: This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals. ... Faculty members report the following financial relationships: Andrew A. Nierenberg, MD, has disclosed the following ...


Allergan Medicaid Rebate Suit Redo Denied At 3rd Circ.
Law360
Law360 (September 26, 2018, 7:11 PM EDT) -- The Third Circuit on Wednesday again refused to revive a pharmaceutical executive's suit claiming Allergan Inc. and other drug manufacturers shorted the federal government on drug rebate payments.


Global ATM Outsourcing Market Research Report 2018: Market ...
Amazing Newshub
Global Asthma Medication Market Report 2018- The Asthma Medication Market report provides global coverage of Asthma Medication market.

e mais »

Asthma Medication Market Analysis by Professional Reviews and Opinions 2018
Trade Market Research
In 2017, the global Asthma Medication market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The Global Asthma Medication Market Report provides a complete market analysis of the ...


marketresearchday.com

Desloratadine Market Forecast by 2025: Top Companies, Growth ...
marketresearchday.com
Desloratadine Market report provides a detailed analysis of the factors that are driving and restraining the demand for Desloratadine. Desloratadine market ...

e mais »

Find Market Research By Abhishek Budholiya (press release) (blog)

Current and Projected Allergy Treatment Market size in terms of volume and value 2016-2026
Find Market Research By Abhishek Budholiya (press release) (blog)
... Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and Vicks. Currently, the companies which operate in allergy ...

e mais »

Latest Market Reports By Abhishek Budholiya (press release) (blog)

Expansion of Allergy Treatment Market During 2016-2026 to Gain Robust Traction
Latest Market Reports By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.


Photocure ASA: Daniel Schneider appointed Chief Executive Officer
GlobeNewswire (press release)
Mr Schneider has also held executive management positions in other pharmaceutical and biotech companies, including BTG International, Somaxon Pharmaceuticals and Sepracor. ... The US headquarters for Photocure Inc., are in Princeton, New Jersey.

e mais »

Tullahoma News and Guardian

Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis Appointed as CEO
Business Wire (press release)
Mike has held senior roles at GE Life Sciences, Millipore and Sepracor, where he managed technologies directed at diagnostics, genomics, proteomics, bioprocessing and drug development. ?In Nautic, Mikart has found the ideal partner to continue scaling ...
Nautic Partners buys MikartPE Hub (blog)

todos os 9 artigos de notícias »

OutSourcing-Pharma.com

GA-based CDMO picked up by private equity
OutSourcing-Pharma.com
Mikart, Inc. provides a range of services, including formulation development, clinical trial supplies, regulatory filing support, as well as clinical and commercial manufacturing, among others. According to the company, ongoing investments in the ...


United States Desloratadine Market 2018- 2025|Details Analysis By Top Key Players Pfizer, Teva, Wante ...
MENAFN.COM
(MENAFN Editorial) iCrowdNewswire - Oct 15, 2018. In this report, the United States Desloratadine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

e mais »

Industry News Updates (press release) (blog)

Global Desloratadine Market 2018-2025 Development Trends, Key Manufacturers and Competitive Analysis
Industry News Updates (press release) (blog)
The 2018 market research report on Desloratadine Market is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge. The Desloratadine market report will shed light on many critical points and trends of ...

e mais »

LANews By Abhishek Budholiya (press release) (blog)

Allergy Treatment Market to Register Steady Expansion During 2016-2026
LANews By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

e mais »

The Future Gadgets

Desloratadine Market Industry- 2018 Marketable Price, Growth Rate and Product Development Analysis 2023
The Future Gadgets
Pfizer; Teva; Wante Pharmaceutical; Novartis India Limited; Mylan; Sepracor; Sandoz; Apollo Pharmaceuticals; GSK; Mayne Pharma Inc; Abhilasha Pharma Pvt; Abbott; Takeda; Schering-Plough; Nanjing Hicin Pharmaceutical; Hairui Pharmaceutical; Hainan ...

e mais »

Alter Times

Global Desloratadine Market Research Report 2018: Analysis, Scope, Share, Progress, Trends And Forecast ...
Alter Times
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters